SARASIN & PARTNERS LLP – Eli Lilly and Company Transaction History
SARASIN & PARTNERS LLP portfolio value:
$16.69M
portfolio value
SARASIN & PARTNERS LLP quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -38.49% | -32.31K shares | -10.52M | $323.35 | 51.64K |
Q2 2022 | share | Decrease | -34.28% | -43.79K shares | -9.36M | $324.23 | 83.95K |
Q1 2022 | share | 0.00% | 0 shares | 1.29M | $286.37 | 127.75K | |
Q4 2021 | share | 0.00% | 0 shares | 5.77M | $277.25 | 127.75K | |
Q3 2021 | share | 0.00% | 0 shares | 196K | $230.3 | 127.75K | |
Q2 2021 | share | Increase | +4.48% | 5.48K shares | 6.47M | $228.04 | 127.75K |
Q1 2021 | share | Decrease | -20.07% | -30.69K shares | -2.98M | $184.81 | 122.27K |
Q4 2020 | share | Increase | +17.77% | 23.08K shares | 6.60M | $166.32 | 152.96K |
Q3 2020 | share | Increase | +125.54% | 72.29K shares | 9.77M | $145.05 | 129.88K |
Q2 2020 | share | 0.00% | 0 shares | 1.46M | $160.1 | 57.58K | |
Q1 2020 | share | Increase | +29.30% | 13.04K shares | 2.13M | $134.64 | 57.58K |
Q4 2019 | share | 0.00% | 0 shares | 873K | $126.91 | 44.54K | |
Q3 2019 | share | Increase | +62.53% | 17.13K shares | 1.94M | $107.36 | 44.54K |
Q2 2019 | share | Increase | +4.54% | 1.19K shares | -365K | $105.74 | 27.40K |
Q1 2019 | share | 0.00% | 0 shares | 368K | $123.17 | 26.21K | |
Q4 2018 | share | Decrease | -21.28% | -7.08K shares | -541K | $109.26 | 26.21K |
Q3 2018 | share | Increase | 0.00% | 33.30K shares | 3.57M | $100.8 | 33.30K |